Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy

Por Camp, ER, Wang, C, Little, EC, Watson, PM, Pirollo, KF, Rait, A, Cole, DJ, Chang, EH, Watson, DK
Publicado em 2013